Cas:958885-86-4 Epivitexolide D manufacturer & supplier

We serve Chemical Name:Epivitexolide D CAS:958885-86-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Epivitexolide D

Chemical Name:Epivitexolide D
CAS.NO:958885-86-4
Synonyms:2(5H)-Furanone, 3-[(1R)-2-[(1S,4aS,8aS)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-1-hydroxyethyl]-;3-{(1R)-1-Hydroxy-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2(5H)-furanone
Molecular Formula:C20H30O3
Molecular Weight:318.450
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:468.0±20.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.535
PSA:46.53000
Exact Mass:318.219482
LogP:5.46

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2(5H)-Furanone, 3-[(1R)-2-[(1S,4aS,8aS)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-1-hydroxyethyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-{(1R)-1-Hydroxy-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2(5H)-furanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2(5H)-Furanone, 3-[(1R)-2-[(1S,4aS,8aS)-decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]-1-hydroxyethyl]- Use and application,3-{(1R)-1-Hydroxy-2-[(1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2(5H)-furanone technical grade,usp/ep/jp grade.


Related News: New Zealand on Sunday became the latest country to impose restrictions on travelers from mainland China, saying it would deny entry to visitors departing from or transiting through the mainland for two weeks starting on Monday. Epivitexolide D manufacturer Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. Epivitexolide D supplier The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. Epivitexolide D vendor Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells. Epivitexolide D factory Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.